Intracranial Vascular Malformations and Epilepsy

Colin B. Josephson; Felix Rosenow; Rustam Al-Shahi Salman

doi:10.1055/s-0035-1552621

Seminars in Neurology, Inhaltsverzeichnis

Semin Neurol 2015; 35(03): 223-234
DOI: 10.1055/s-0035-1552621

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Intracranial Vascular Malformations and Epilepsy

Autoren

Colin B. Josephson

¹Department of Clinical Neurosciences, University of Calgary, Calgary, AB, Canada
Felix Rosenow

²Epilepsy Center Frankfurt Rhine-Main, Department of Neurology, Center of Neurology and Neurosurgery, Goethe-University Frankfurt, Frankfurt a.M.; Germany

³Epilepsy Center Hessen, Department of Neurology, Philipps-University Marburg, Marburg, Germany
Rustam Al-Shahi Salman

⁴Division of Clinical Neurosciences, Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, United Kingdom

Abstract

Among the spectrum of intracranial vascular malformations (IVMs), arteriovenous malformations (AVMs), and cavernous malformations (CCMs) are of particular importance for epilepsy. Seizures are a common mode of presentation for both conditions. Seizures may occur de novo or secondary to intracerebral hemorrhage. Timely imaging is thus crucial for patients with seizures and AVMs or CCMs. Patients with a first-ever AVM- or CCM-related seizure can now be considered to have epilepsy according to the International League Against Epilepsy criteria. Observational studies and case series suggest that between 45 to 78% of patients with AVM-related epilepsy and 47 to 60% of patients with CCM-related epilepsy may achieve seizure freedom through antiepileptic drugs (AEDs) alone. Invasive procedures are available although current evidence suggests that epilepsy-specific preintervention evaluations are underused. Randomized controlled trials and population-based studies have demonstrated worse short-term functional outcomes after routine intervention on unruptured AVMs or CCMs when compared with conservative management. The role of invasive therapy for IVM-related epilepsy has yielded mixed results. Case series have reported high estimates of seizure freedom although these results have not been replicated in controlled observational studies. Randomized controlled trials of immediate invasive therapy versus conservative management, in addition to usual care with AEDs and of different types of treatment and their timing, are warranted for AVMs and CCM-related epilepsy.

Keywords

arteriovenous malformations - cavernous malformations - epilepsy - antiepileptic drugs - epilepsy surgery

Volltext

Referenzen

References
1 Morris Z, Whiteley WN, Longstreth Jr WT , et al. Incidental findings on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2009; 339: b3016
2 Al-Shahi R, Bhattacharya JJ, Currie DG , et al; Scottish Intracranial Vascular Malformation Study Collaborators. Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 2003; 34 (5) 1163-1169
3 Josephson CB, Leach JP, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R ; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. Seizure risk from cavernous or arteriovenous malformations: prospective population-based study. Neurology 2011; 76 (18) 1548-1554
4 Gabriel RA, Kim H, Sidney S , et al. Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke 2010; 41 (1) 21-26
5 Brown Jr RD, Wiebers DO, Torner JC, O'Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology 1996; 46 (4) 949-952
6 National Institute for Health and Care Excellence. The epilepsies: the diagnosis and management of the epilepsies in adults and children in primary and secondary care. NICE clinical guideline 137. London, UK: National Institute for Health and Care Excellence; 2013
7 Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults: a national clinical guideline. SIGN guideline 70. Edinburgh, UK: Scottish Intercollegiate Guidelines Network; 2003
8 Krumholz A, Wiebe S, Gronseth G , et al; Quality Standards Subcommittee of the American Academy of Neurology; American Epilepsy Society. Practice Parameter: evaluating an apparent unprovoked first seizure in adults (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2007; 69 (21) 1996-2007
9 Al-Shahi Salman R, Berg MJ, Morrison L, Awad IA ; Angioma Alliance Scientific Advisory Board. Hemorrhage from cavernous malformations of the brain: definition and reporting standards. Stroke 2008; 39 (12) 3222-3230
10 Al-Shahi Salman R, Hall JM, Horne MA , et al; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) collaborators. Untreated clinical course of cerebral cavernous malformations: a prospective, population-based cohort study. Lancet Neurol 2012; 11 (3) 217-224
11 Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL ; MARS Coinvestigators. Untreated brain arteriovenous malformation: patient-level meta-analysis of hemorrhage predictors. Neurology 2014; 83 (7) 590-597
12 Pitkänen A. Therapeutic approaches to epileptogenesis—hope on the horizon. Epilepsia 2010; 51 (Suppl. 03) 2-17
13 Carreno M, Lüders H. General principles of presurgical evaluation. In: Lüders H, Comair YG, , eds. Epilepsy Surgery. 2nd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2001
14 Rosenow F, Lüders H. Presurgical evaluation of epilepsy. Brain 2001; 124 (Pt 9) 1683-1700
15 Gilmore R, Morris III H, Van Ness PC, Gilmore-Pollak W, Estes M. Mirror focus: function of seizure frequency and influence on outcome after surgery. Epilepsia 1994; 35 (2) 258-263
16 Babb TL, Brown WJ, Pretorius J, Davenport C, Lieb JP, Crandall PH. Temporal lobe volumetric cell densities in temporal lobe epilepsy. Epilepsia 1984; 25 (6) 729-740
17 Engel Jr J. Seizures and Epilepsy. 2nd ed. New York, NY: Oxford University Press; 2013
18 Salazar AM, Jabbari B, Vance SC, Grafman J, Amin D, Dillon JD. Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury Study. Neurology 1985; 35 (10) 1406-1414
19 Herzig R, Bogousslavsky J, Maeder P , et al. Intracranial arterial and arteriovenous malformations presenting with infarction. Lausanne Stroke Registry Study. Eur J Neurol 2005; 12 (2) 93-102
20 Zschocke S. [Pathogenesis of epileptic seizures in patients with cerebral arteriovenous angioma. The role of cerebral ischemia (author's transl)]. Fortschr Neurol Psychiatr Grenzgeb 1974; 42 (9) 433-453
21 Fierstra J, Conklin J, Krings T , et al. Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. Brain 2011; 134 (Pt 1) 100-109
22 Yeh HS, Kashiwagi S, Tew Jr JM, Berger TS. Surgical management of epilepsy associated with cerebral arteriovenous malformations. J Neurosurg 1990; 72 (2) 216-223
23 Leone MA, Ivashynka AV, Tonini MC , et al; ARES (Alcohol Related Seizures) study group. Risk factors for a first epileptic seizure symptomatic of brain tumour or brain vascular malformation. A case control study. Swiss Med Wkly 2011; 141: w13155
24 Awad I, Jabbour P. Cerebral cavernous malformations and epilepsy. Neurosurg Focus 2006; 21 (1) e7
25 Clatterbuck RE, Eberhart CG, Crain BJ, Rigamonti D. Ultrastructural and immunocytochemical evidence that an incompetent blood-brain barrier is related to the pathophysiology of cavernous malformations. J Neurol Neurosurg Psychiatry 2001; 71 (2) 188-192
26 Willmore LJ, Sypert GW, Munson JB. Recurrent seizures induced by cortical iron injection: a model of posttraumatic epilepsy. Ann Neurol 1978; 4 (4) 329-336
27 von Essen C, Rydenhag B, Nyström B, Mozzi R, van Gelder N, Hamberger A. High levels of glycine and serine as a cause of the seizure symptoms of cavernous angiomas?. J Neurochem 1996; 67 (1) 260-264
28 Seiffert E, Dreier JP, Ivens S , et al. Lasting blood-brain barrier disruption induces epileptic focus in the rat somatosensory cortex. J Neurosci 2004; 24 (36) 7829-7836
29 Blümcke I, Thom M, Aronica E , et al. The clinicopathologic spectrum of focal cortical dysplasias: a consensus classification proposed by an ad hoc Task Force of the ILAE Diagnostic Methods Commission. Epilepsia 2011; 52 (1) 158-174
30 Li LM, Cendes F, Andermann F , et al. Surgical outcome in patients with epilepsy and dual pathology. Brain 1999; 122 (Pt 5) 799-805
31 Giulioni M, Marucci G, Martinoni M , et al. Seizure outcome in surgically treated drug-resistant mesial temporal lobe epilepsy based on the recent histopathological classifications. J Neurosurg 2013; 119 (1) 37-47
32 Yeh HS, Privitera MD. Secondary epileptogenesis in cerebral arteriovenous malformations. Arch Neurol 1991; 48 (11) 1122-1124
33 Ferrier CH, Aronica E, Leijten FS , et al. Electrocorticography discharge patterns in patients with a cavernous hemangioma and pharmacoresistent epilepsy. J Neurosurg 2007; 107 (3) 495-503
34 Loescher W. Strategies for antiepileptogenesis: Antiepileptic drugs versus novel approaches evaluated in post-status epilepticus models of temporal lobe epilepsy. In Noebels JL, Avoli M, Rogawski MA, , et al , eds. Jasper's Basic Mechanisms of the Epilepsies. 4th ed. Bethesda, MD: National Center for Biotechnology Information; 2012
35 Andrade-Souza YM, Ramani M, Scora D, Tsao MN, TerBrugge K, Schwartz ML. Radiosurgical treatment for rolandic arteriovenous malformations. J Neurosurg 2006; 105 (5) 689-697
36 Eisenschenk S, Gilmore RL, Friedman WA, Henchey RA. The effect of LINAC stereotactic radiosurgery on epilepsy associated with arteriovenous malformations. Stereotact Funct Neurosurg 1998; 71 (2) 51-61
37 Englot DJ, Young WL, Han SJ, McCulloch CE, Chang EF, Lawton MT. Seizure predictors and control after microsurgical resection of supratentorial arteriovenous malformations in 440 patients. Neurosurgery 2012; 71 (3) 572-580 , discussion 580
38 Ghossoub M, Nataf F, Merienne L , et al. [Evolution of epileptic seizures associated with cerebral arteriovenous malformations after radiosurgery]. Neurochirurgie 2001; 47 (2-3 Pt 2) 344-349
39 Heikkinen ER, Konnov B, Melnikov L , et al. Relief of epilepsy by radiosurgery of cerebral arteriovenous malformations. Stereotact Funct Neurosurg 1989; 53 (3) 157-166
40 Heros RC, Korosue K, Diebold PM. Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery 1990; 26 (4) 570-577 , discussion 577–578
41 Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy CS. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery 2002; 51 (2) 303-309 , discussion 309–311
42 Hyun SJ, Kong DS, Lee JI, Kim JS, Hong SC. Cerebral arteriovenous malformations and seizures: differential impact on the time to seizure-free state according to the treatment modalities. Acta Neurochir (Wien) 2012; 154 (6) 1003-1010
43 Kida Y, Kobayashi T, Tanaka T, Mori Y, Hasegawa T, Kondoh T. Seizure control after radiosurgery on cerebral arteriovenous malformations. J Clin Neurosci 2000; 7 (Suppl. 01) 6-9
44 Kjellberg RN, Hanamura T, Davis KR, Lyons SL, Adams RD. Bragg-peak proton-beam therapy for arteriovenous malformations of the brain. N Engl J Med 1983; 309 (5) 269-274
45 Korosue K, Hara Y, Tamaki N, Heros RC. Long-term prognosis of seizures after complete surgical resection of AVMs of the brain. Japanese Journal of Neurosurgery 1994; 3: 10-17
46 Kurita H, Kawamoto S, Suzuki I , et al. Control of epilepsy associated with cerebral arteriovenous malformations after radiosurgery. J Neurol Neurosurg Psychiatry 1998; 65 (5) 648-655
47 Le Feuvre D, Taylor A. Target embolization of AVMs: Identification of sites and results of treatment. Interv Neuroradiol 2007; 13 (4) 389-394
48 Lim YJ, Lee CY, Koh JS, Kim TS, Kim GK, Rhee BA. Seizure control of Gamma Knife radiosurgery for non-hemorrhagic arteriovenous malformations. Acta Neurochir Suppl (Wien) 2006; 99: 97-101
49 Lv X, Li Y, Jiiang C, Yang X, Wu Z. Brain arteriovenous malformations and endovascular treatment: effect on seizures. Interv Neuroradiol 2010; 16 (1) 39-45
50 Pertuiset B, Sichez JP, Philippon J, Fohanno D, Horn Y. [Mortality and morbidity after complete surgical removal of 162 intracranial arteriovenous malformations (author's transl)]. Rev Neurol (Paris) 1979; 135 (4) 319-327
51 Piepgras DG, Sundt Jr TM, Ragoowansi AT, Stevens L. Seizure outcome in patients with surgically treated cerebral arteriovenous malformations. J Neurosurg 1993; 78 (1) 5-11
52 Schäuble B, Cascino GD, Pollock BE , et al. Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations. Neurology 2004; 63 (4) 683-687
53 Steiner L, Lindquist C, Adler JR, Torner JC, Alves W, Steiner M. Clinical outcome of radiosurgery for cerebral arteriovenous malformations. J Neurosurg 1992; 77 (1) 1-8
54 Sutcliffe JC, Forster DM, Walton L, Dias PS, Kemeny AA. Untoward clinical effects after stereotactic radiosurgery for intracranial arteriovenous malformations. Br J Neurosurg 1992; 6 (3) 177-185
55 Thorpe ML, Cordato DJ, Morgan MK, Herkes GK. Postoperative seizure outcome in a series of 114 patients with supratentorial arteriovenous malformations. J Clin Neurosci 2000; 7 (2) 107-111
56 Yang SY, Kim DG, Chung HT, Paek SH. Radiosurgery for unruptured cerebral arteriovenous malformations: long-term seizure outcome. Neurology 2012; 78 (17) 1292-1298
57 Zeiler FA, McDonald PJ, Kaufmann A , et al. Gamma knife for cerebral arteriovenous malformations at a single centre. Can J Neurol Sci 2011; 38 (6) 851-857
58 Miserocchi G, Sironi VA, Ravagnati L. [Epilepsy in arteriovenous malformations: considerations on 174 cases]. Bollettino - Lega Italiana contro l'Epilessia 1984 45–46. 267-269 [Italian]
59 Crawford PM, West CR, Chadwick DW, Shaw MDM. Arteriovenous malformations of the brain: natural history in unoperated patients. J Neurol Neurosurg Psychiatry 1986; 49 (1) 1-10
60 Galletti F, Costa C, Cupini LM , et al. Brain arteriovenous malformations and seizures: an Italian study. J Neurol Neurosurg Psychiatry 2014; 85 (3) 284-288
61 Hofmeister C, Stapf C, Hartmann A , et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke 2000; 31 (6) 1307-1310
62 Garcin B, Houdart E, Porcher R , et al. Epileptic seizures at initial presentation in patients with brain arteriovenous malformation. Neurology 2012; 78 (9) 626-631
63 Hillman J. Population-based analysis of arteriovenous malformation treatment. J Neurosurg 2001; 95 (4) 633-637
64 Jessurun GA, Kamphuis DJ, van der Zande FH, Nossent JC. Cerebral arteriovenous malformations in The Netherlands Antilles. High prevalence of hereditary hemorrhagic telangiectasia-related single and multiple cerebral arteriovenous malformations. Clin Neurol Neurosurg 1993; 95 (3) 193-198
65 Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990; 73 (3) 387-391
66 Jiang P, Lv X, Wu Z , et al. Characteristics of brain arteriovenous malformations presenting with seizures without acute or remote hemorrhage. Neuroradiol J 2011; 24 (6) 886-888
67 Stapf C, Khaw AV, Sciacca RR , et al. Effect of age on clinical and morphological characteristics in patients with brain arteriovenous malformation. Stroke 2003; 34 (11) 2664-2669
68 Turjman F, Massoud TF, Sayre JW, Viñuela F, Guglielmi G, Duckwiler G. Epilepsy associated with cerebral arteriovenous malformations: a multivariate analysis of angioarchitectural characteristics. AJNR Am J Neuroradiol 1995; 16 (2) 345-350
69 Crawford PM, West CR, Shaw MD, Chadwick DW. Cerebral arteriovenous malformations and epilepsy: factors in the development of epilepsy. Epilepsia 1986; 27 (3) 270-275
70 Aiba T, Tanaka R, Koike T, Kameyama S, Takeda N, Komata T. Natural history of intracranial cavernous malformations. J Neurosurg 1995; 83 (1) 56-59
71 Bertalanffy H, Kühn G, Scheremet R, Seeger W. Indications for surgery and prognosis in patients with cerebral cavernous angiomas. Neurol Med Chir (Tokyo) 1992; 32 (9) 659-666
72 Cantu C, Murillo-Bonilla L, Arauz A, Higuera J, Padilla J, Barinagarrementeria F. Predictive factors for intracerebral hemorrhage in patients with cavernous angiomas. Neurol Res 2005; 27 (3) 314-318
73 Consales A, Piatelli G, Ravegnani M , et al. Treatment and outcome of children with cerebral cavernomas: a survey on 32 patients. Neurol Sci 2010; 31 (2) 117-123
74 D'Angelo VA, De Bonis C, Amoroso R , et al. Supratentorial cerebral cavernous malformations: clinical, surgical, and genetic involvement. Neurosurg Focus 2006; 21 (1) e9
75 Del Curling Jr O, Kelly Jr DL, Elster AD, Craven TE. An analysis of the natural history of cavernous angiomas. J Neurosurg 1991; 75 (5) 702-708
76 Di Rocco C, Iannelli A, Tamburrini G. Cavernomas of the central nervous system in children. A report of 22 cases. Acta Neurochir (Wien) 1996; 138 (11) 1267-1274 , discussion 1273–1274
77 Farmer JP, Cosgrove GR, Villemure JG, Meagher-Villemure K, Tampieri D, Melanson D. Intracerebral cavernous angiomas. Neurology 1988; 38 (11) 1699-1704
78 Flemming KD, Link MJ, Christianson TJ, Brown Jr RD. Prospective hemorrhage risk of intracerebral cavernous malformations. Neurology 2012; 78 (9) 632-636
79 Kim DS, Park YG, Choi JU, Chung SS, Lee KC. An analysis of the natural history of cavernous malformations. Surg Neurol 1997; 48 (1) 9-17 , discussion 17–18
80 Kitamura K, Fukui M, Oka K , et al. Hemangiomas of the central nervous system in Japan: an epidemiological and clinicopathological study with special reference to venous and cavernous malformations. Neurosurg Rev 1986; 9 (3) 221-231
81 Kondziolka D, Lunsford LD, Kestle JR. The natural history of cerebral cavernous malformations. J Neurosurg 1995; 83 (5) 820-824
82 Moriarity JL, Wetzel M, Clatterbuck RE , et al. The natural history of cavernous malformations: a prospective study of 68 patients. Neurosurgery 1999; 44 (6) 1166-1171 , discussion 1172–1173
83 Murillo-Bonilla LM, Cantú-Brito C, Arauz-Góngora A, Higuera-Calleja J, Padilla-Rubio J, Barinagarrementeria-Aldatz F. [Cavernous angioma. Clinical observations and prognosis of 133 patients]. Rev Invest Clin 2003; 55 (4) 387-393
84 Porter PJ, Willinsky RA, Harper W, Wallace MC. Cerebral cavernous malformations: natural history and prognosis after clinical deterioration with or without hemorrhage. J Neurosurg 1997; 87 (2) 190-197
85 Robinson JR, Awad IA, Little JR. Natural history of the cavernous angioma. J Neurosurg 1991; 75 (5) 709-714
86 Shih YH, Pan DH. Management of supratentorial cavernous malformations: craniotomy versus gammaknife radiosurgery. Clin Neurol Neurosurg 2005; 107 (2) 108-112
87 Xia C, Zhang R, Mao Y, Zhou L. Pediatric cavernous malformation in the central nervous system: report of 66 cases. Pediatr Neurosurg 2009; 45 (2) 105-113
88 Zabramski JM, Wascher TM, Spetzler RF , et al. The natural history of familial cavernous malformations: results of an ongoing study. J Neurosurg 1994; 80 (3) 422-432
89 Zevgaridis D, van Velthoven V, Ebeling U, Reulen HJ. Seizure control following surgery in supratentorial cavernous malformations: a retrospective study in 77 patients. Acta Neurochir (Wien) 1996; 138 (6) 672-677
90 Menzler K, Chen X, Thiel P , et al. Epileptogenicity of cavernomas depends on (archi-) cortical localization. Neurosurgery 2010; 67 (4) 918-924
91 Mossa-Basha M, Chen J, Gandhi D. Imaging of cerebral arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am 2012; 23 (1) 27-42
92 Ferrara AR. Brain arteriovenous malformations. Radiol Technol 2011; 82 (6) 543MR-556MR
93 Rigamonti D, Hadley MN, Drayer BP , et al. Cerebral cavernous malformations. Incidence and familial occurrence. N Engl J Med 1988; 319 (6) 343-347
94 Sigal R, Krief O, Houtteville JP, Halimi P, Doyon D, Pariente D. Occult cerebrovascular malformations: follow-up with MR imaging. Radiology 1990; 176 (3) 815-819
95 Josephson CB, White PM, Krishan A, Al-Shahi Salman R. Computed tomography angiography or magnetic resonance angiography for detection of intracranial vascular malformations in patients with intracerebral haemorrhage. Cochrane Database Syst Rev 2014; 9: CD009372
96 Desai A, Bekelis K, Thadani VM , et al. Interictal PET and ictal subtraction SPECT: sensitivity in the detection of seizure foci in patients with medically intractable epilepsy. Epilepsia 2013; 54 (2) 341-350
97 Duncan JS. Imaging and epilepsy. Brain 1997; 120 (Pt 2) 339-377
98 Wehner T, Lüders H. Role of neuroimaging in the presurgical evaluation of epilepsy. J Clin Neurol 2008; 4 (1) 1-16
99 Kalamangalam GP, Pestana Knight EM, Visweswaran S, Gupta A. Noninvasive predictors of subdural grid seizure localization in children with nonlesional focal epilepsy. J Clin Neurophysiol 2013; 30 (1) 45-50
100 la Fougère C, Rominger A, Förster S, Geisler J, Bartenstein P. PET and SPECT in epilepsy: a critical review. Epilepsy Behav 2009; 15 (1) 50-55
101 Pittau F, Grouiller F, Spinelli L, Seeck M, Michel CM, Vulliemoz S. The role of functional neuroimaging in pre-surgical epilepsy evaluation. Front Neurol 2014; 5: 31
102 Leblanc R, Meyer E. Functional PET scanning in the assessment of cerebral arteriovenous malformations. Case report. J Neurosurg 1990; 73 (4) 615-619
103 Alonso-Vanegas MA, Cisneros-Franco JM, Otsuki T. Surgical management of cavernous malformations presenting with drug-resistant epilepsy. Front Neurol 2011; 2: 86
104 Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol 2014; 13 (11) 1114-1126
105 Cascino GD. Video-EEG monitoring in adults. Epilepsia 2002; 43 (Suppl. 03) 80-93
106 von der Brelie C, Schramm J. Cerebral cavernous malformations and intractable epilepsy: the limited usefulness of current literature. Acta Neurochir (Wien) 2011; 153 (2) 249-259
107 Fisher RS, Acevedo C, Arzimanoglou A , et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55 (4) 475-482
108 Stephen LJ, Kwan P, Brodie MJ. Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?. Epilepsia 2001; 42 (3) 357-362
109 Rosenow F, Alonso-Vanegas MA, Baumgartner C , et al; Surgical Task Force, Commission on Therapeutic Strategies of the ILAE. Cavernoma-related epilepsy: review and recommendations for management—report of the Surgical Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2013; 54 (12) 2025-2035
110 Churchyard A, Khangure M, Grainger K. Cerebral cavernous angioma: a potentially benign condition? Successful treatment in 16 cases. J Neurol Neurosurg Psychiatry 1992; 55 (11) 1040-1045
111 Stavrou I, Baumgartner C, Frischer JM, Trattnig S, Knosp E. Long-term seizure control after resection of supratentorial cavernomas: a retrospective single-center study in 53 patients. Neurosurgery 2008; 63 (5) 888-896 , discussion 897
112 Mohr JP, Parides MK, Stapf C , et al; international ARUBA investigators. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014; 383 (9917) 614-621
113 Al-Shahi Salman R, White PM, Counsell CE , et al; Scottish Audit of Intracranial Vascular Malformations Collaborators. Outcome after conservative management or intervention for unruptured brain arteriovenous malformations. JAMA 2014; 311 (16) 1661-1669
114 Josephson CB, Bhattacharya JJ, Counsell CE , et al; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. Seizure risk with AVM treatment or conservative management: prospective, population-based study. Neurology 2012; 79 (6) 500-507
115 Murphy MJ. Long-term follow-up of seizures associated with cerebral arteriovenous malformations. Results of therapy. Arch Neurol 1985; 42 (5) 477-479
116 Baranoski JF, Grant RA, Hirsch LJ , et al. Seizure control for intracranial arteriovenous malformations is directly related to treatment modality: a meta-analysis. J Neurointerv Surg 2014; 6 (9) 684-690
117 Hyun SJ, Kong DS, Lee JI, Kim JS, Hong SC. Cerebral arteriovenous malformations and seizures: differential impact on the time to seizure-free state according to the treatment modalities. Acta Neurochir (Wien) 2012; 154 (6) 1003-1010
118 van Beijnum J, van der Worp HB, Buis DR , et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 2011; 306 (18) 2011-2019
119 Poorthuis M, Samarasekera N, Kontoh K , et al. Comparative studies of the diagnosis and treatment of cerebral cavernous malformations in adults: systematic review. Acta Neurochir (Wien) 2013; 155 (4) 643-649
120 Moultrie F, Horne MA, Josephson CB , et al; Scottish Audit of Intracranial Vascular Malformations (SAIVMs) steering committee and collaborators. Outcome after surgical or conservative management of cerebral cavernous malformations. Neurology 2014; 83 (7) 582-589
121 Poorthuis MH, Klijn CJ, Algra A, Rinkel GJ, Al-Shahi Salman R. Treatment of cerebral cavernous malformations: a systematic review and meta-regression analysis. J Neurol Neurosurg Psychiatry 2014; 85 (12) 1319-1323
122 Casazza M, Broggi G, Franzini A , et al. Supratentorial cavernous angiomas and epileptic seizures: preoperative course and postoperative outcome. Neurosurgery 1996; 39 (1) 26-32 , discussion 32–34
123 Chang EF, Gabriel RA, Potts MB, Garcia PA, Barbaro NM, Lawton MT. Seizure characteristics and control after microsurgical resection of supratentorial cerebral cavernous malformations. Neurosurgery 2009; 65 (1) 31-37 , discussion 37–38
124 Cohen DS, Zubay GP, Goodman RR. Seizure outcome after lesionectomy for cavernous malformations. J Neurosurg 1995; 83 (2) 237-242
125 Ferroli P, Casazza M, Marras C, Mendola C, Franzini A, Broggi G. Cerebral cavernomas and seizures: a retrospective study on 163 patients who underwent pure lesionectomy. Neurol Sci 2006; 26 (6) 390-394
126 Baumann CR, Schuknecht B, Lo Russo G , et al. Seizure outcome after resection of cavernous malformations is better when surrounding hemosiderin-stained brain also is removed. Epilepsia 2006; 47 (3) 563-566
127 Yeon JY, Kim JS, Choi SJ, Seo DW, Hong SB, Hong SC. Supratentorial cavernous angiomas presenting with seizures: surgical outcomes in 60 consecutive patients. Seizure 2009; 18 (1) 14-20
128 San-Juan D, Díaz-Nuñez IC, Ojeda-Baldéz M , et al. Utility of electrocorticography in the surgical treatment of cavernomas presenting with pharmacoresistant epilepsy. Epileptic Disord 2014; 16 (3) 245-260
129 Stefan H, Hammen T. Cavernous haemangiomas, epilepsy and treatment strategies. Acta Neurol Scand 2004; 110 (6) 393-397
130 Rocamora R, Mader I, Zentner J, Schulze-Bonhage A. Epilepsy surgery in patients with multiple cerebral cavernous malformations. Seizure 2009; 18 (4) 241-245
131 Chen DJ, Severson E, Prayson RA. Cavernous angiomas in chronic epilepsy associated with focal cortical dysplasia. Clin Neuropathol 2013; 32 (1) 31-36
132 Menzler K, Thiel P, Hermsen A , et al. The role of underlying structural cause for epilepsy classification: clinical features and prognosis in mesial temporal lobe epilepsy caused by hippocampal sclerosis versus cavernoma. Epilepsia 2011; 52 (4) 707-711
133 Nagy G, Kemeny AA. Stereotactic radiosurgery of intracranial cavernous malformations. Neurosurg Clin N Am 2013; 24 (4) 575-589
134 Liu KD, Chung WY, Wu HM , et al. Gamma knife surgery for cavernous hemangiomas: an analysis of 125 patients. J Neurosurg 2005; 102 (Suppl): 81-86
135 Régis J, Bartolomei F, Kida Y , et al. Radiosurgery for epilepsy associated with cavernous malformation: retrospective study in 49 patients. Neurosurgery 2000; 47 (5) 1091-1097
136 Wang P, Zhang F, Zhang H, Zhao H. Gamma knife radiosurgery for intracranial cavernous malformations. Clin Neurol Neurosurg 2010; 112 (6) 474-477
137 Hsu PW, Chang CN, Tseng CK , et al. Treatment of epileptogenic cavernomas: surgery versus radiosurgery. Cerebrovasc Dis 2007; 24 (1) 116-120 , discussion 121
138 Egger M, Smith GD. Meta-Analysis. Potentials and promise. BMJ 1997; 315 (7119) 1371-1374
139 Kwan P, Arzimanoglou A, Berg AT , et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010; 51 (6) 1069-1077
140 Engel JC, Ness PCV, Rasmussen TB, Ojemann LM. Outcome with respect to epileptic seizures. In: Engel Jr J, , ed. Surgical treatment of the epilepsies. New York, NY: Raven Press; 1993
141 Wieser HG, Blume WT, Fish D , et al; Commission on Neurosurgery of the International League Against Epilepsy (ILAE). ILAE Commission Report. Proposal for a new classification of outcome with respect to epileptic seizures following epilepsy surgery. Epilepsia 2001; 42 (2) 282-286
142 Stewart LA, Clarke MJ ; Cochrane Working Group. Practical methodology of meta-analyses (overviews) using updated individual patient data. Stat Med 1995; 14 (19) 2057-2079
143 Stewart LA, Parmar MK. Meta-analysis of the literature or of individual patient data: is there a difference?. Lancet 1993; 341 (8842) 418-422
144 Stewart LA, Tierney JF. To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data. Eval Health Prof 2002; 25 (1) 76-97
145 Simmonds MC, Higgins JP, Stewart LA, Tierney JF, Clarke MJ, Thompson SG. Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin Trials 2005; 2 (3) 209-217
146 Schwartz TH. Epilepsy surgeons, rather than vascular neurosurgeons, should operate on cavernous malformations that cause seizures-a modest proposal. Epilepsy Curr 2010; 10 (3) 59-60
147 Englot DJ, Han SJ, Lawton MT, Chang EF. Predictors of seizure freedom in the surgical treatment of supratentorial cavernous malformations. J Neurosurg 2011; 115 (6) 1169-1174
148 von der Brelie C, Malter MP, Niehusmann P, Elger CE, von Lehe M, Schramm J. Surgical management and long-term seizure outcome after epilepsy surgery for different types of epilepsy associated with cerebral cavernous malformations. Epilepsia 2013; 54 (9) 1699-1706